1. Home
  2. BHE vs WVE Comparison

BHE vs WVE Comparison

Compare BHE & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benchmark Electronics Inc.

BHE

Benchmark Electronics Inc.

HOLD

Current Price

$55.50

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.04

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHE
WVE
Founded
1979
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
BHE
WVE
Price
$55.50
$12.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$55.00
$31.47
AVG Volume (30 Days)
262.7K
2.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$2,659,108,000.00
$3,704,000.00
Revenue This Year
$6.84
N/A
Revenue Next Year
$6.02
$119.93
P/E Ratio
$82.35
N/A
Revenue Growth
0.11
149.43
52 Week Low
$30.73
$5.28
52 Week High
$61.12
$21.73

Technical Indicators

Market Signals
Indicator
BHE
WVE
Relative Strength Index (RSI) 49.11 39.19
Support Level $42.45 $6.61
Resistance Level $60.82 $14.50
Average True Range (ATR) 1.84 0.71
MACD -0.23 -0.18
Stochastic Oscillator 50.70 16.10

Price Performance

Historical Comparison
BHE
WVE

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: